Aims & Scope: Current Gene Therapy

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Read more: https://bit.ly/3v5t1zq

Aims and scope: Current Pharmacogenomics and Personalized Medicine

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.

CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from qualified authors in any global region including the Central and Latin American countries, Asia-Pacific and developing countries.

The Journal scope is defined by three inter-connected aims. First, we are interested in genomics/postgenomic biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and they can be mechanistically substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology that collectively shape postgenomic future(s) and innovation trajectories in life sciences. Priority will be given to expert reviews and research articles that include original ideas and findings related to the journal scope and mandate.

This journal follows the International Committee of Medical Journal Editors (ICMJE) (www.icmje.org) guidance for authorship, peer review and editorial independence. All manuscripts submitted for publication will be immediately subjected to editorial scrutiny. Manuscripts that do not conform to the CPPM format and editorial style will be returned to the authors. Only those articles that may potentially pass the rigorous standards of the peer review process are sent out for critical appraisal by independent expert referees invited from the international editorial board and the broader scientific community.

CPPM offers a transdisciplinary, peer-reviewed and intellectually stimulating forum for academic researchers, health professionals, pharmaceutical and biotechnology industries, policy makers, government and global health stakeholders interested in pharmacogenomics and global personalized medicine. The journal is published four times per year and printed on acid-free paper.

Learn more: https://bit.ly/3SWOMe4

Aims & Scope: Current Psychiatry Research and Reviews

Current Psychiatry Research & Reviews publishes peer-reviewed expert reviews, original research articles and single topic guest-edited issues dedicated to clinical research on all the latest advances in clinical psychiatry and its related areas, e.g. pharmacology, epidemiology, clinical care and therapy. The journal is essential reading for all clinicians, psychiatrists and researchers working in the field of psychiatry. The aims and scope of the journal cover all aspects of mental, emotional, and behavioral disorders in humans, such as depression, panic disorder, PTSD, anxiety, obsessive-compulsive disorder, borderline personality disorder, eating disorders, delusions and hallucinations, psychosis, bipolar disorder, insomnia, substance use disorder, addictive behavior, etc. In addition, treatment of such diseases through psychotherapy, medications, psychosocial interventions, and somatic treatment is also included.

Journals Impacting Science – Current Pharmaceutical Analysis

AIMS & SCOPE

Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis. To know more about the Journal, please visit: https://benthamscience.com/journals/current-pharmaceutical-analysis/

Aims & Scope | Current Medical Imaging

 

cmim-flyer

 

AIMS & SCOPE

Current Medical Imaging publishes frontier review articles, original research articles, case reports, drug clinical trial studies and guest edited thematic issues on all the latest advances on medical imaging dedicated to clinical research. All relevant areas are covered by the journal, including advances in the diagnosis, instrumentation and therapeutic applications related to all modern medical imaging techniques.

The journal is essential reading for all clinicians and researchers involved in medical imaging and diagnosis. To know more about the Journal, please visit: https://benthamscience.com/journals/current-medical-imaging/

Aims & Scope | Letters in Drug Design & Discovery

lddd-flyer

 

AIMS & SCOPE

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Aims & Scope | Current Pharmaceutical Analysis

 

AIMS & SCOPE

Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

 

cpa-flyer.jpg

Aims & Scope | Current Computer-Aided Drug Design

 

AIMS & SCOPE

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews/mini-reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.

 

ccadd-flyer.jpg

Aims & Scope | Mini-Reviews in Organic Chemistry

AIMS & SCOPE

Mini-Reviews in Organic Chemistryis a peer reviewed journal which publishes original reviews/mini reviews on all areas of organic chemistry including organic synthesis, bioorganic and medicinal chemistry, natural product chemistry, molecular recognition, and physical organic chemistry. The emphasis will be on publishing quality papers very rapidly, without any charges.

The journal encourages submission of reviews on emerging fields of organic chemistry including:

  • Bioorganic Chemistry
  • Carbohydrate Chemistry
  • Chemical Biology
  • Chemical Process Research
  • Computational Organic Chemistry
  • Development of Synthetic Methodologies
  • Functional Organic Materials
  • Heterocyclic Chemistry
  • Macromolecular Chemistry
  • Natural Products Isolation And Synthesis
  • New Synthetic Methodology
  • Organic Reactions
  • Organocatalysis
  • Organometallic Chemistry
  • Theoretical Organic Chemistry
  • Polymer Chemistry
  • Stereochemistry
  • Structural Investigations
  • Supramolecular Chemistry

 

mroc-flyer.jpg

Aims and Scope | Current Bioinformatics

Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science.

The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.

Current Bioinformatics is an essential journal for all academic and industrial researchers who want expert knowledge on all major advances in bioinformatics. To know more about the journal, please visit: https://benthamscience.com/journals/current-bioinformatics/

 

cbio-flyer.jpg

%d bloggers like this: